Accurate risk assessment is a highly technical process for patients with acute myeloid leukemia (AML). A new tool could help make such assessments available even when patients can’t get to a specialty ...
Launched in production in 2020, Notabene’s Travel Rule solution now processes transactions among 50 crypto exchanges. Cryptocurrency exchanges Bitfinex is preparing to test out a new Anti-Money ...
Genomic profiling enables therapy individualization when actionable mutations (FLT3, NPM1, IDH1/2, TP53) are present, moving AML care beyond one-size-fits-all induction and transplant algorithms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results